Everus Construction Group Statistics
Total Valuation
ECG has a market cap or net worth of $8.18 billion. The enterprise value is $8.66 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ECG has 51.04 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 51.04M |
| Shares Outstanding | 51.04M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 88.66% |
| Float | 50.85M |
Valuation Ratios
The trailing PE ratio is 36.66 and the forward PE ratio is 39.92. ECG's PEG ratio is 3.00.
| PE Ratio | 36.66 |
| Forward PE | 39.92 |
| PS Ratio | 2.17 |
| Forward PS | 2.02 |
| PB Ratio | 12.51 |
| P/TBV Ratio | 15.80 |
| P/FCF Ratio | 37.41 |
| P/OCF Ratio | 29.28 |
| PEG Ratio | 3.00 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 26.94, with an EV/FCF ratio of 37.72.
| EV / Earnings | 38.76 |
| EV / Sales | 2.19 |
| EV / EBITDA | 26.94 |
| EV / EBIT | 29.72 |
| EV / FCF | 37.72 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.77 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 1.58 |
| Interest Coverage | 14.26 |
Financial Efficiency
Return on equity (ROE) is 38.95% and return on invested capital (ROIC) is 26.82%.
| Return on Equity (ROE) | 38.95% |
| Return on Assets (ROA) | 11.37% |
| Return on Invested Capital (ROIC) | 26.82% |
| Return on Capital Employed (ROCE) | 27.92% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $420,927 |
| Profits Per Employee | $23,767 |
| Employee Count | 9,400 |
| Asset Turnover | 2.47 |
| Inventory Turnover | 72.64 |
Taxes
In the past 12 months, ECG has paid $78.99 million in taxes.
| Income Tax | 78.99M |
| Effective Tax Rate | 26.12% |
Stock Price Statistics
The stock price has increased by +247.51% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +247.51% |
| 50-Day Moving Average | 125.99 |
| 200-Day Moving Average | 96.16 |
| Relative Strength Index (RSI) | 66.66 |
| Average Volume (20 Days) | 626,638 |
Short Selling Information
The latest short interest is 1.79 million, so 3.51% of the outstanding shares have been sold short.
| Short Interest | 1.79M |
| Short Previous Month | 1.68M |
| Short % of Shares Out | 3.51% |
| Short % of Float | 3.53% |
| Short Ratio (days to cover) | 3.72 |
Income Statement
In the last 12 months, ECG had revenue of $3.96 billion and earned $223.41 million in profits. Earnings per share was $4.37.
| Revenue | 3.96B |
| Gross Profit | 492.32M |
| Operating Income | 291.45M |
| Pretax Income | 302.40M |
| Net Income | 223.41M |
| EBITDA | 321.43M |
| EBIT | 291.45M |
| Earnings Per Share (EPS) | $4.37 |
Full Income StatementBalance Sheet
The company has $293.36 million in cash and $362.59 million in debt, with a net cash position of -$69.23 million or -$1.36 per share.
| Cash & Cash Equivalents | 293.36M |
| Total Debt | 362.59M |
| Net Cash | -69.23M |
| Net Cash Per Share | -$1.36 |
| Equity (Book Value) | 686.94M |
| Book Value Per Share | 13.46 |
| Working Capital | 617.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $293.39 million and capital expenditures -$63.77 million, giving a free cash flow of $229.63 million.
| Operating Cash Flow | 293.39M |
| Capital Expenditures | -63.77M |
| Depreciation & Amortization | 29.98M |
| Net Borrowing | -15.00M |
| Free Cash Flow | 229.63M |
| FCF Per Share | $4.50 |
Full Cash Flow StatementMargins
Gross margin is 12.44%, with operating and profit margins of 7.37% and 5.65%.
| Gross Margin | 12.44% |
| Operating Margin | 7.37% |
| Pretax Margin | 7.64% |
| Profit Margin | 5.65% |
| EBITDA Margin | 8.12% |
| EBIT Margin | 7.37% |
| FCF Margin | 5.80% |
Dividends & Yields
ECG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | -0.09% |
| Earnings Yield | 2.60% |
| FCF Yield | 2.67% |
Analyst Forecast
The average price target for ECG is $127.00, which is -20.79% lower than the current price. The consensus rating is "Buy".
| Price Target | $127.00 |
| Price Target Difference | -20.79% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 9.45% |
| EPS Growth Forecast (5Y) | 11.86% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
